Factory-CRO is a leading contract research organisation (“CRO”) focused exclusively on the fast-growing medical device market in Europe and North America. Founded in 1994, the business offers a full suite of trial management services to its global client base across a broad range of therapeutic areas, including orthopaedic, cardiovascular, dermatology and aesthetics.
The market for medical device CROs is growing quickly, driven by an increasingly stringent regulatory regime, underlying growth in medical device sales and an increasing propensity to outsource.
Factory-CRO is headquartered in Bilthoven, Netherlands.
Factory-CRO is Kester Capital’s second investment in the CRO market after its successful investment in Chiltern International.